Identification and outcomes of acute kidney disease in patients presenting in Bolivia, Brazil, South Africa, and Nepal.

IF 15.8 1区 医学 Q1 Medicine
Rhys D R Evans, Sanjib K Sharma, Rolando Claure-Del Granado, Brett Cullis, Emmanuel A Burdmann, Fos Franca, Junio Aguiar, Martyn Fredlund, Kelly Hendricks, Maria F Iturricha-Caceres, Mamit Rai, Bhupendra Shah, Shyam Kafle, David C Harris, Mike V Rocco
{"title":"Identification and outcomes of acute kidney disease in patients presenting in Bolivia, Brazil, South Africa, and Nepal.","authors":"Rhys D R Evans, Sanjib K Sharma, Rolando Claure-Del Granado, Brett Cullis, Emmanuel A Burdmann, Fos Franca, Junio Aguiar, Martyn Fredlund, Kelly Hendricks, Maria F Iturricha-Caceres, Mamit Rai, Bhupendra Shah, Shyam Kafle, David C Harris, Mike V Rocco","doi":"10.1371/journal.pmed.1004495","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The International Society of Nephrology proposes an acute kidney disease (AKD) management strategy that includes a risk score to aid AKD identification in low- and low-middle-income countries (LLMICs). We investigated the performance of the risk score and determined kidney and patient outcomes from AKD at multiple LLMIC sites.</p><p><strong>Methods and findings: </strong>Adult patients presenting to healthcare facilities in Bolivia, Brazil, South Africa, and Nepal were screened using a symptom-based risk score and clinical judgment. Those at AKD risk underwent serum creatinine testing, predominantly with a point-of-care (POC) device. Clinical data were collected prospectively between September 2018 and November 2020. We analyzed risk score performance and determined AKD outcomes at discharge and over follow-up of 90 days. A total of 4,311 patients were at increased risk of AKD, and 2,922 (67.8%) had AKD confirmed. AKD prevalence was 80.2% in patients enrolled based on the risk score and 32.5% when enrolled on clinical judgment alone (p < 0.0001). The area under the receiver operating characteristic curve was 0.73 for the risk score to detect AKD. Death during admission occurred in 84 (2.9%) patients with AKD and 3 (0.2%) patients without kidney disease (p < 0.0001). Death after discharge occurred in 206 (9.7%) AKD patients, and 1865 AKD patients underwent reassessment of kidney function after discharge; 902 (48.4%) patients had persistent kidney disease including 740 (39.7%) patients reclassified with de novo or previously undiagnosed chronic kidney disease (CKD). The study was pragmatically designed to assess outcomes as part of routine healthcare, and there was heterogeneity in clinical practice and outcomes between sites, in addition to selection bias during cohort identification.</p><p><strong>Conclusions: </strong>The use of a risk score can aid AKD identification in LLMICs. High rates of persistent kidney disease and mortality after discharge highlight the importance of AKD follow-up in low-resource settings.</p>","PeriodicalId":49008,"journal":{"name":"PLoS Medicine","volume":"21 11","pages":"e1004495"},"PeriodicalIF":15.8000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLoS Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1371/journal.pmed.1004495","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The International Society of Nephrology proposes an acute kidney disease (AKD) management strategy that includes a risk score to aid AKD identification in low- and low-middle-income countries (LLMICs). We investigated the performance of the risk score and determined kidney and patient outcomes from AKD at multiple LLMIC sites.

Methods and findings: Adult patients presenting to healthcare facilities in Bolivia, Brazil, South Africa, and Nepal were screened using a symptom-based risk score and clinical judgment. Those at AKD risk underwent serum creatinine testing, predominantly with a point-of-care (POC) device. Clinical data were collected prospectively between September 2018 and November 2020. We analyzed risk score performance and determined AKD outcomes at discharge and over follow-up of 90 days. A total of 4,311 patients were at increased risk of AKD, and 2,922 (67.8%) had AKD confirmed. AKD prevalence was 80.2% in patients enrolled based on the risk score and 32.5% when enrolled on clinical judgment alone (p < 0.0001). The area under the receiver operating characteristic curve was 0.73 for the risk score to detect AKD. Death during admission occurred in 84 (2.9%) patients with AKD and 3 (0.2%) patients without kidney disease (p < 0.0001). Death after discharge occurred in 206 (9.7%) AKD patients, and 1865 AKD patients underwent reassessment of kidney function after discharge; 902 (48.4%) patients had persistent kidney disease including 740 (39.7%) patients reclassified with de novo or previously undiagnosed chronic kidney disease (CKD). The study was pragmatically designed to assess outcomes as part of routine healthcare, and there was heterogeneity in clinical practice and outcomes between sites, in addition to selection bias during cohort identification.

Conclusions: The use of a risk score can aid AKD identification in LLMICs. High rates of persistent kidney disease and mortality after discharge highlight the importance of AKD follow-up in low-resource settings.

玻利维亚、巴西、南非和尼泊尔急性肾病患者的识别和治疗结果。
背景:国际肾脏病学会(International Society of Nephrology)提出了一项急性肾脏病(AKD)管理策略,其中包括风险评分,以帮助低收入和中低收入国家(LLMICs)识别急性肾脏病。我们对风险评分的性能进行了调查,并确定了多个中低收入国家的急性肾脏病肾脏和患者的预后:我们使用基于症状的风险评分和临床判断对玻利维亚、巴西、南非和尼泊尔医疗机构的成年患者进行了筛查。有急性肾功能衰竭风险的患者接受血清肌酐检测,主要是通过一种护理点 (POC) 设备进行检测。临床数据在 2018 年 9 月至 2020 年 11 月期间进行了前瞻性收集。我们分析了风险评分表现,并确定了出院时和随访 90 天后的 AKD 结果。共有 4311 名患者的 AKD 风险增高,其中 2922 人(67.8%)确诊为 AKD。根据风险评分入选的患者中,AKD 患病率为 80.2%,而仅根据临床判断入选的患者中,AKD 患病率为 32.5%(P < 0.0001)。风险评分检测 AKD 的接收者操作特征曲线下面积为 0.73。84 名(2.9%)AKD 患者和 3 名(0.2%)无肾病患者在入院时死亡(P < 0.0001)。206名(9.7%)AKD患者在出院后死亡,1865名AKD患者在出院后接受了肾功能重新评估;902名(48.4%)患者患有持续性肾病,其中740名(39.7%)患者被重新归类为新发或之前未确诊的慢性肾病(CKD)。该研究的设计非常实用,旨在评估作为常规医疗保健一部分的结果,不同地点的临床实践和结果存在异质性,此外在队列识别过程中还存在选择偏差:结论:使用风险评分可以帮助内陆医疗中心识别肾脏疾病。出院后肾病持续率和死亡率都很高,这凸显了在低资源环境中进行AKD随访的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
PLoS Medicine
PLoS Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
17.60
自引率
0.60%
发文量
227
审稿时长
4-8 weeks
期刊介绍: PLOS Medicine is a prominent platform for discussing and researching global health challenges. The journal covers a wide range of topics, including biomedical, environmental, social, and political factors affecting health. It prioritizes articles that contribute to clinical practice, health policy, or a better understanding of pathophysiology, ultimately aiming to improve health outcomes across different settings. The journal is unwavering in its commitment to uphold the highest ethical standards in medical publishing. This includes actively managing and disclosing any conflicts of interest related to reporting, reviewing, and publishing. PLOS Medicine promotes transparency in the entire review and publication process. The journal also encourages data sharing and encourages the reuse of published work. Additionally, authors retain copyright for their work, and the publication is made accessible through Open Access with no restrictions on availability and dissemination. PLOS Medicine takes measures to avoid conflicts of interest associated with advertising drugs and medical devices or engaging in the exclusive sale of reprints.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信